Tiragolumab
Tiragolumab (MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT) .Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer.
Product Specifications
CAS Number
1918185-84-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1140873-01 0.02 mg (E-Coli)
Recombinant Yersinia pestis Glyoxylate/hydroxypyruvate reductase B (ghrB)
Ask
View Details 
MBS1140873-02 0.02 mg (Yeast)
Recombinant Yersinia pestis Glyoxylate/hydroxypyruvate reductase B (ghrB)
Ask
View Details 
MBS1140873-03 0.1 mg (E-Coli)
Recombinant Yersinia pestis Glyoxylate/hydroxypyruvate reductase B (ghrB)
Ask
View Details MBS1140873-04 0.1 mg (Yeast)
Recombinant Yersinia pestis Glyoxylate/hydroxypyruvate reductase B (ghrB)
Ask
View Details MBS1140873-05 0.02 mg (Baculovirus)
Recombinant Yersinia pestis Glyoxylate/hydroxypyruvate reductase B (ghrB)
Ask
View Details MBS1140873-06 0.02 mg (Mammalian-Cell)
Recombinant Yersinia pestis Glyoxylate/hydroxypyruvate reductase B (ghrB)
Ask
View Details